Articles Published in 2011

FDA approves generic olanzapine injection

Thursday, October 27, 2011 10:40 AM

The FDA has approved INNOPHARMA’s Abbreviated New Drug Application (ANDA) for olanzapine injection (the generic equivalent of ZyprexaR injection).

More... »

Nerualstem completes phase Ia MDD trial

Thursday, October 27, 2011 10:29 AM

Neuralstem has completed phase Ia in the ongoing safety trial to test its neuroregenerative small molecule drug, NSI-189, in the treatment of major depressive disorder (MDD).  Phase Ia tested the drug in healthy volunteers for safety and tolerability. Phase Ib, which the company expects to commence later this year, will test the safety and tolerability of NSI-189 in depressed patients.

More... »

GSK, University of Edinburgh partner in drug discovery

Wednesday, October 26, 2011 12:53 PM

GlaxoSmithKline (GSK) and the University of Edinburgh have agreed on a collaborative partnership to discover and develop medicines with the potential to treat severe acute pancreatitis.

More... »

XOMA, Aragen Bioscience collaborate

Wednesday, October 26, 2011 12:20 PM

XOMA and Aragen Bioscience have entered into an agreement under which Aragen Bioscience will provide its clients access to XOMA’s proprietary Human Engineering technology for antibody humanization. Financial terms were not disclosed.

More... »

Quintiles to acquire Advion BioServices

Wednesday, October 26, 2011 12:01 PM

Quintiles has agreed to buy Advion BioServices, a 19-year-old bioanalytical lab that recently penned a strategic partnership with Eli Lilly.

More... »

Life Technologies, GSK ink cancer research agreement

Wednesday, October 26, 2011 10:55 AM

Life Technologies has signed an agreement with GlaxoSmithKline to develop a diagnostic to be used as a companion test with a GSK candidate cancer immunotherapy. Life will develop a qPCR-based molecular diagnostic assay for GSK's MAGE-A3 cancer immunotherapy candidate designed to identify patients likely to benefit from the immunotherapy.

More... »

Immune Design, Sanofi collaborate in allergy research

Wednesday, October 26, 2011 10:39 AM

Immune Design has entered into an early-stage research collaboration with Sanofi-Aventis to investigate the use of IDC's Glucopyranosyl Lipid Adjuvant (GLA) technology, a toll–like receptor 4 (TLR-4) agonist, in the field of allergy.

More... »

OBA launches IRMS mobile application

Wednesday, October 26, 2011 10:20 AM

Online Business Applications (OBA) has released its mobile request application, IRMS Mobile, for iPad, iPhone and other mobile devices.

More... »

VTT, MSI open Center for Bioengineering in California

Wednesday, October 26, 2011 10:14 AM

The VTT Technical Research Centre of Finland and the Molecular Sciences Institute (MSI) have joined forces to establish a new research center in Berkeley, California.

More... »

Sequenom names Huang to ophthalmology advisory board

Tuesday, October 25, 2011 02:47 PM

Sequenom, a life sciences company providing innovative genetic analysis solutions, has named Suber Huang, M.D., to its ophthalmology clinical advisory board.

More... »